<DOC>
	<DOCNO>NCT02836067</DOCNO>
	<brief_summary>The purpose study learn smoke affect immune system people HIV infection . The investigator would like know HIV infected smoker quit smoke different response tissue people keep smoking .</brief_summary>
	<brief_title>Impact Smoking Its Cessation Systemic Airway Immune Activation</brief_title>
	<detailed_description />
	<criteria>HIV infect ART ≥ 6 month virologically suppress ( &lt; 50 copy/ml ) time enrollment Selfreported total ≥100 cigarettes currently active confirm positive salivary cotinine verification screen Laboratory value within 28 day prior enrollment meet follow criterion : Hemoglobin ≥ 10.0 g/dL Absolute neutrophil count ≥ 1000/mm3 Platelet count ≥ 80,000/mm3 Prothrombin time ( PT ) &lt; 1.5 x upper limit normal ( ULN ) Partial thromboplastin time ( PTT ) &lt; 1.5 x ULN Negative urine pregnancy test ( sensitive 25 IU HCG ) screen within 24 hour study procedure female participant Ability willingness give write informed consent comply study requirement . Pregnant breastfeeding le 8 week postpartum . Active malignancy Significant immunological illnesses/deficiencies Use immunomodulatory agent within 30 day prior study enrollment . Recent active illness ( 2 month ) History tuberculosis , lung cancer , asthma bronchiectasis COPD GOLD Stage 34 base screening spirometry . Subjects meet inclusion exclusion criterion undergo spirometry . Aim 1 : Only HIV smoker diagnosis COPD ; normal spirometry FEV1/FVC &gt; 0.7 . Aim 2 : HIV smoker evidence COPD GOLD Stage 12 ( mildmoderate ) enrol . All screen participant know COPD spirometry diagnosis GOLD Stage 34 exclude due safety bronchoscopy . A history alcohol dependence within 6 month prior screen visit . History underlying medical condition antibiotic prophylaxis invasive procedure require . History intolerance , sensitivity , allergy anaphylaxis benzodiazepine narcotic used procedure . History intolerance , sensitivity , allergy anaphylaxis lidocaine amide anesthetic , well benzocaine ester type anesthetic . History coronary artery disease , myocardial infarction , chronic renal failure , decompensated cirrhosis , condition opinion investigator compromise ability participate study . Currently take anticoagulant include limited : heparin ( HepLock , HepPak ) , HepPak CVC , Heparin Lock Flush ) , warfarin ( Coumadin ) , tinzaparin ( Innohep ) , enoxaparin ( Lovenox ) , danaparoid ( Orgaran ) , dalteparin ( Fragmin ) , clopidogrel ( Plavix ) , prophylactic aspirin , regular NSAID use . Subject take following medication : systemic steroid ( inhale nasal steroid therapy permit ) , interleukins , systemic interferon ( e.g. , local injection interferon alpha treatment HPV permit ) systemic chemotherapy . Prior recipient HIV vaccine . Recent abdominal cataract surgery Investigator discretion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>